Guidelines for the Use of Retrievable and Convertible Vena Cava Filters: Report from the Society of Interventional Radiology Multidisciplinary Consensus Conference

Kaufman, John A.; Kinney, Thomas B.; Streiff, Michael B.; Sing, Ronald F.; Proctor, Mary C.; Becker, Daniel M.; Cipolle, Mark; Comerota, Anthony J.; Millward, Steven F.; Rogers, Frederick B.; Sacks, David; Venbrux, Anthony C.

doi:10.1097/01.rvi.0000203418-39769.0d

Cited by 348 publications

(133 citation statements)

References 90 publications

Supporting

Mentioning

128

Contrasting

Unclassified

Order By: Relevance

“…No accessible route to vena cava and no location available in vena cava are contraindications to filter placement [4, 22]. …”

Section: Indications and Contraindicationsmentioning

confidence: 99%

Retrievable Inferior Vena Cava Filters for Venous Thromboembolism

Win

2013

ISRN Radiology

View full text Add to dashboard Cite

Inferior vena cava (IVC) filters are used as an alternative to anticoagulants for prevention of fatal pulmonary embolism (PE) in venous thromboembolic disorders. Retrievable IVC filters have become an increasingly attractive option due to the long-term risks of permanent filter placement. These devices are shown to be technically feasible in insertion and retrieval percutaneously while providing protection from PE. Nevertheless, there are complications and failed retrievals with these retrievable filters. The aim of the paper is to review the retrievable filters and their efficacy, safety, and retrievability.

show abstract

“…No accessible route to vena cava and no location available in vena cava are contraindications to filter placement [4, 22]. …”

Section: Indications and Contraindicationsmentioning

confidence: 99%

Retrievable Inferior Vena Cava Filters for Venous Thromboembolism

Win

2013

ISRN Radiology

View full text Add to dashboard Cite

show abstract

“…RF retrieval was attempted only in patients with absent or minimal thrombus trapped in the RF. Our approach follows the recommendations later set forth by the SIR Multidisciplinary Consensus Conference [17]. …”

Section: Methodsmentioning

confidence: 99%

The Impact of Cancer on the Clinical Outcome of Patients After Inferior Vena Cava Filter Placement

Narayan

Hong²,

Streiff³

et al. 2016

American Journal of Clinical Oncology

View full text Add to dashboard Cite

Objectives Inferior vena cava (IVC) filters are placed to prevent pulmonary embolism (PE) however some studies have suggested that IVC filters are associated with exacerbated risks of deep vein/IVC thrombosis in cancer patients. The purpose of this study is to determine if cancer patients develop higher than expected rates of venous thromboembolism complications after filter placement compared with non-cancer patients. Methods A retrospective cohort study of consecutive patients who received filters (2002-2006) at Johns Hopkins was conducted. Exposures and outcomes were obtained by chart review. Relative risks (RR, 95%CI) for outcomes in cancer versus non-cancer patients were estimated using multistate models. Results The cohort included 702 patients – 246 with cancer and 456 without. Cancer patients were older, more likely to be white and have filters placed for contraindications to anticoagulation (p<0.01). The most common cancers were lung (11.8%) and colorectal (10.6%). Cancer patients had an increase in venous thromboembolism (RR 1.9, (1.1,3.2)) due to more DVT/IVC thrombosis (RR 1.7, (1.0,3.0)). Higher PE rates in cancer were not statistically significant (RR 2.2, (0.8,5.8)). Conclusions Cancer patients have elevated risks of thrombotic complications compared with non-cancer patients however these risks are not higher than expected based on historical controls.

show abstract

“…Anticoagulant therapy is often associated with critical contraindications such as severe bleeding as a result of low platelet count, brain metastasis, and severe hypertension (Bates and Ginsberg 2004). The absolute contraindications to anticoagulant therapy are hemorrhagic stroke, intracranial hemorrhage, and gastrointestinal hemorrhage (Kaufman et al 2006). The relative contraindications include recent major surgery or trauma, uncontrolled hypertension, renal or hepatic disease, and positive guaiac stool test (Liu et al 2012).…”

Section: Therapeutic Modalities For Dvtmentioning

confidence: 99%

Deep vein thrombosis: Current status and nanotechnology advances

Wadajkar

Santimano

Rahimi

et al. 2013

Biotechnology Advances

View full text Add to dashboard Cite

Deep vein thrombosis (DVT) affects up to 2 million people in the United States, and worldwide incidence is 70 to 113 cases per 100,000 per year. Mortality from DVT is often due to subsequent pulmonary embolism (PE). Precise diagnosis and treatment is thereby essential for the management of DVT. DVT is diagnosed by a thorough history and physical examination followed by laboratory and diagnostic tests. The choice of laboratory and diagnostic test is dependent on clinical pretest probability. Available laboratory and diagnostic techniques mainly involve D-dimer test, ultrasound, venography, and magnetic resonance imaging. The latter two diagnostic tools require high doses of contrast agents including either radioactive or toxic materials. The available treatment options include lifestyle modifications, mechanical compression, anticoagulant therapy, inferior vena cava filter, and thrombolysis/thrombolectomy. All of these medical and surgical treatments have serious side effects including improper clot clearance and increased risk of hemorrhage occurrence. Therefore, research in this field has recently focused on the development of non-invasive and accurate diagnostics, such as ultrasound enhanced techniques and molecular imaging methods, to assess thrombus location and its treatment course. The frontier of nanomedicine also shows high prospects in tackling DVT with efficient targeted drug delivery. This review describes the pathology of DVT along with successive medical problems such as PE and features a detailed listing of various diagnostic and therapeutic modalities that have been in use and are under development.

show abstract

Guidelines for the Use of Retrievable and Convertible Vena Cava Filters: Report from the Society of Interventional Radiology Multidisciplinary Consensus Conference

Cited by 348 publications

References 90 publications

Retrievable Inferior Vena Cava Filters for Venous Thromboembolism

Retrievable Inferior Vena Cava Filters for Venous Thromboembolism

The Impact of Cancer on the Clinical Outcome of Patients After Inferior Vena Cava Filter Placement

Deep vein thrombosis: Current status and nanotechnology advances

Contact Info

Product

Resources

About